In several cancer types, the antitumor effects of chemerin have been linked to increased recruitment of innate immune defense components, natural killer and T cells [15,19] or suppression of the inflammatory tumor microenvironment and myeloid-derived suppressive cell accumulation [20]. The gene discussed is RARRES2; the disease is neoplasm.